这个转述的雅虎新闻根本就是一个标题党A/Prof Kenneth Mak的原话是
There is a significant risk of vaccine breakthrough with the Sinovac vaccine.
其实这种breakthrough在新加坡前不久就已经发生过了,就是樟宜机场的case
参阅straitstimes的文章
https://www.straitstimes.com/singapore/health/sciencetalk-vaccination-is-key-to-singapores-fight-against-covid-19
Asymptomatic or mild symptoms for breakthrough infections
Like many other vaccines that are currently in use, the mRNA Covid-19 vaccines are not 100 per cent effective.
However, it is noteworthy that many of these breakthrough infections were picked up as a result of routine swabbing, and not because these individuals were ill.
雅虎的这篇文章把标题写成significant problems有博眼球之嫌
多谢分享 确实有标题党之嫌
但是文章里的一段话还是让我觉得有点惊讶的,sinovac给新加坡政府的数据还是不足 这都一年了
Sinovac remains unregistered and is not authorised by the Health Sciences Authority (HSA), and is to be provided only under the SAR framework. As such, it will not be covered under the Vaccine Injury Financial Assistance Programme (VIFAP) meant for the national vaccination programme.
Prof Mak noted that there still is some "outstanding data" on the vaccine that Sinovac has not provided to HSA, which is required to give "complete assurance" about its quality and safety profile. "We look forward, if data becomes available for us, then to (commence) this process of evaluation but unfortunately we're not able to do so."
Sinovac remains unregistered and is not authorised by the Health Sciences Authority (HSA), and is to be provided only under the SAR framework. As such, it will not be covered under the Vaccine Injury Financial Assistance Programme (VIFAP) meant for the national vaccination programme.
Prof Mak noted that there still is some "outstanding data" on the vaccine that Sinovac has not provided to HSA, which is required to give "complete assurance" about its quality and safety profile. "We look forward, if data becomes available for us, then to (commence) this process of evaluation but unfortunately we're not able to do so."
[本文发送自华新iOS APP]